Related references
Note: Only part of the references are listed.Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease
Tharick A. Pascoal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
[18F]ODIBO: a prosthetic group for bioorthogonal radiolabeling of macromolecules via strain-promoted alkyne-azide cycloaddition
Mehdi Boudjemeline et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
cGMP production of the radiopharmaceutical [18F]MK-6240 for PET imaging of human neurofibrillary tangles
Thomas Lee Collier et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F}-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Abbas M. Walji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D. Hostetler et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future
Manuela Ariza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
Timothy M. Shoup et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
[18F] Azadibenzocyclooctyne ([18F]ADIBO): A biocompatible radioactive labeling synthon for peptides using catalyst free [3+2] cycloaddition
Selvanathan Arumugam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Share Paper
